Fifty-fifth Legislature                                                         

Second Regular Session                                                          

 

COMMITTEE ON HEALTH & HUMAN SERVICES

HOUSE OF REPRESENTATIVES AMENDMENTS TO H.B. 2490

(Reference to printed bill)

 

 

 


Page 13, line 17, after "requirements;" insert "rules;"

Line 21, after "section" insert "to initiate, monitor and modify drug therapy or provide disease management assistance"

Line 24, after "duties" insert "related to drug therapy and disease management"

Line 25, after "including" insert "drug therapy that the pharmacist may initiate, monitor and modify and"; strike "may be ordered" insert "the pharmacist may order"

Line 28, strike "medical"

Line 29, after the first "pharmacist" insert "through disease MANAGEMENT and drug therapy management"

Between lines 30 and 31, insert:

"3. Specify that the pharmacist must follow the written drug therapy and disease management guidelines provided by the provider and may provide drug therapy and disease management services only pursuant to those guidelines.  The guidelines shall specify, at a minimum, the specific drug, drugs or drug classes and the conditions to be managed by the pharmacist, the conditions and events for which the pharmacist must notify the provider and the laboratory tests the pharmacist may order."

Line 32, after "must" strike remainder of line

Line 33, strike "examination on or"

Page 14, between lines 3 and 4, insert:

"F. The Arizona state board of pharmacy, the Arizona medical board, the Arizona board of osteopathic examiners in medicine and surgery and the Arizona state board of nursing may adopt rules relating to collaborative practice agreements."

Reletter to conform

Line 6, strike "specifies the patient care" insert "outlines the drug therapy and disease management"

Strike line 7

Line 8, strike "a patient's drug therapy," insert "including initiating, monitoring and modifying prescription drug and laboratory test orders"

Between lines 10 and 11, insert:

"2. Initiate, monitor and modify does not include a pharmacist's selection of drug products that are not prescribed by the provider unless the selection of specific drug products is authorized by the collaborative practice agreement."

Renumber to conform

Amend title to conform


And, as so amended, it do pass

 

JOANNE H. OSBORNE

CHAIRMAN

 

 

2490HEALTH  HUMAN SERVICES

02/14/2022

06:03 PM

H: ra